MHV370
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for MHV370, covering 2024-07-08 to 2024-07-08. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Evaluate the Safety, Tolerability and Efficacy of MHV370 in Participants With Sjogren's Syndrome (SjS) or Mixed Connective Tissue Disease (MCTD) [Phase 2]